Lacopat

Lacosamide, the active ingredient in Lacopat, is a anti‑epileptic presented as a intravenous solution for intravenous use. It treats partial‑onset seizures in patients with epilepsy.\n\nGNH India supplies Lacopat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacopat is an anti‑epileptic drug indicated for the management of focal seizure disorders.\n\nPartial‑onset seizures: reduces seizure frequency in epilepsy patients.\nAdjunctive therapy in epilepsy: improves overall seizure control when added to existing regimens.\nRefractory focal epilepsy: provides additional seizure reduction for patients not fully controlled by other medications.

Common Side Effects:\n- Dizziness\n- Headache\n- Nausea\n- Fatigue\n- Diplopia (double vision)\n- Blurred vision\n\nSerious or Rare Side Effects:\n- Prolongation of PR interval leading to cardiac conduction delays\n- Suicidal thoughts or behavior\n- Severe skin reactions (e.g., Stevens‑Johnson syndrome)\n- Anaphylactic reactions\n- Hepatic enzyme elevations\n- Severe hypotension

Precautions for Lacopat include careful patient assessment and monitoring.\n\nAssess cardiac function: monitor ECG for PR‑interval changes.\nReview renal function: adjust use in patients with significant impairment.\nAvoid abrupt discontinuation: taper under medical supervision to prevent seizure worsening.\nUse caution in hepatic impairment: monitor liver enzymes regularly.\nStore at ambient temperature: keep in original container, protect from moisture and light.

Lacopat may interact with several medications.\n\nMajor Interactions (Avoid):\n- Concomitant strong CYP3A4 inhibitors: may increase lacosamide plasma levels.\n- Co‑administration with drugs that prolong PR interval (e.g., class IA antiarrhythmics): risk of cardiac conduction delay.\n- Use with other sodium‑channel blockers: additive central nervous system depression.\n\nModerate Interactions (Monitor Closely):\n- Combination with carbamazepine: may reduce lacosamide concentrations.\n- Use with oral contraceptives: possible reduced contraceptive efficacy.\n- Concurrent alcohol consumption: may enhance dizziness and sedation.